Session

New and novel hemophilia therapies, the latest updates from clinical trials.

Abstract submissions for the New and novel hemophilia therapies, the latest updates from clinical trials sessions opens on May 1, 2019. The deadline for abstract submission is extended to September 13, 2019.


Guidelines

The purpose of this presentation submission is to provide an abstract for a talk to be given during the Global Forum.

  • One presentation per company or organization will be accepted.
  • Scientific presentations only.
  • The proposed presentation must include new, or the latest, data from clinical trials. (If data is not available at time of submission, please submit with available data, which can be updated prior to the presentation).
  • Abstracts should be limited to 350 words.

The number of presentations to be given at the WFH Global Forum is limited, and decisions on acceptance will be based on the relevance and originality of the content for the proposed presentation.


Presentation checklist

  • Title of presentation
  • Presenting author
  • Co-authors
  • Affiliations
  • Background
  • Methods
  • Results
  • Conclusion
The 11th WFH Global Forum is supported by funding from:
Additional support:


Global Forum Secretariat
World Federation of Hemophilia
1425, boul. René-Lévesque Ouest
Bureau 1200 
Montréal, Québec
H3G 1T7 Canada


Tel.: +1 (514) 875-7944
Fax: +1 (514) 875-8916